BioNTech SE (BNTX) Goodwill & Intangibles (2018 - 2025)
BioNTech SE (BNTX) posted Goodwill & Intangibles of $2.3 billion for Q4 2025, up 12.47% on a QoQ basis from $2.0 billion in Q3 2025, and up 83.62% year-over-year from $1.3 billion in Q4 2024.
BioNTech SE (BNTX) has 8 years of Goodwill & Intangibles data on file, last reported at $2.3 billion in Q4 2025.
- In Q4 2025, Goodwill & Intangibles rose 83.62% year-over-year to $2.3 billion; the TTM figure through Dec 2025 stood at $2.3 billion (up 83.62% YoY), while the FY2025 annual figure was $2.2 billion, up 78.22% from the prior year.
- Goodwill & Intangibles rose to $2.3 billion in Q4 2025, from $2.0 billion in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $2.3 billion in Q4 2025 and bottomed at -$16.0 million in Q4 2022.
- A 5-year average of $920.4 million and a median of $834.2 million in 2023 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles tumbled 112.11% — and 2023, when it soared 7936.19%.
- Year by year, Goodwill & Intangibles stood at $132.2 million in 2021, then slumped by 112.11% to -$16.0 million in 2022, then surged by 7936.19% to $1.3 billion in 2023, then declined by 0.31% to $1.3 billion in 2024, then surged by 83.62% to $2.3 billion in 2025.
- The last three Goodwill & Intangibles figures came in at $2.3 billion (Q4 2025), $2.0 billion (Q3 2025), and $2.1 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.30 Bn |
| Sep 30, 2025 | 2.04 Bn |
| Jun 30, 2025 | 2.10 Bn |
| Mar 31, 2025 | 1.99 Bn |
| Dec 31, 2024 | 1.25 Bn |
| Sep 30, 2024 | 1.37 Bn |
| Jun 30, 2024 | 1.33 Bn |
| Mar 31, 2024 | 1.29 Bn |
| Dec 31, 2023 | 1.26 Bn |
| Sep 30, 2023 | 1.12 Bn |
| Jun 30, 2023 | 545.99 Mn |
| Mar 31, 2023 | 406.37 Mn |
| Dec 31, 2022 | -16.02 Mn |
| Sep 30, 2022 | 228.07 Mn |
| Jun 30, 2022 | 236.25 Mn |
| Mar 31, 2022 | 242.42 Mn |
| Dec 31, 2021 | 132.24 Mn |
| Sep 30, 2021 | 192.11 Mn |
| Jun 30, 2021 | 197.62 Mn |
| Mar 31, 2021 | 199.27 Mn |
| Dec 31, 2020 | 71.18 Mn |
| Sep 30, 2020 | 197.09 Mn |
| Jun 30, 2020 | 201.88 Mn |
| Mar 31, 2020 | 103.70 Mn |
| Dec 31, 2019 | 5.95 Mn |
| Sep 30, 2019 | 105.13 Mn |
| Dec 31, 2018 | 101.10 Mn |